Have a personal or library account? Click to login

Therapeutic effect of umbilical cord mesenchymal stem cells on renal ischemia-reperfusion injury

Open Access
|Apr 2025

Authors

Liang Xiao

Department of Surgery and Oncology, Shenzhen Second People’s Hospital/the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China

Chengyu Huang

Shenzhen Zhongjia Biomedical Technology Co., Ltd. Shenzhen, Guangdong, China

Shanghua Xiao

Shenzhen Zhongjia Biomedical Technology Co., Ltd. Shenzhen, Guangdong, China

Lingfeng Xie

Shenzhen Zhongjia Biomedical Technology Co., Ltd. Shenzhen, Guangdong, China

Xueyan Zhang

Shenzhen Zhongjia Biomedical Technology Co., Ltd. Shenzhen, Guangdong, China

Fucheng Xiao

The Center of Campus, Shenzhen Senior High School Group, China

Huajia Cai

Psychiatric Medicine Sophomore, Southern Medical University, China

Shuibo Yang

School of Agriculture and Biotechnology Shenzhen Campus of Sun Yat-sen University Shenzhen, Guangdong, China

Shengqing Wu

Shenzhen Zhongjia Biomedical Technology Co., Ltd. Shenzhen, Guangdong, China

Shoukang Qu

Shenzhen Zhongjia Biomedical Technology Co., Ltd. Shenzhen, Guangdong, China

Jia Liu

ORCID

liujia67@mail.sysu.edu.cn

Shenzhen Zhongjia Biomedical Technology Co., Ltd. Shenzhen, Guangdong, China
School of Agriculture and Biotechnology Shenzhen Campus of Sun Yat-sen University Shenzhen, Guangdong, China
DOI: https://doi.org/10.2478/acph-2025-0006 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 103 - 118
Accepted on: Mar 3, 2025
Published on: Apr 10, 2025
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2025 Liang Xiao, Chengyu Huang, Shanghua Xiao, Lingfeng Xie, Xueyan Zhang, Fucheng Xiao, Huajia Cai, Shuibo Yang, Shengqing Wu, Shoukang Qu, Jia Liu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.